BGNE - BeiGene Ltd - ADR
IEX Last Trade
191.6
-6.900 -3.601%
Share volume: 293,387
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$198.50
-6.90
-3.48%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-02-27 | 2023-05-04 | 2023-08-02 | 2023-11-09 | 2024-02-26 | 2024-05-08 | |
| Cash flow financing | -17.580 M | 120.242 M | -110.366 M | -19.868 M | 166.080 M | -76.782 M | 347.048 M | 162.293 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -379.959 M | -561.906 M | -318.191 M | -563.777 M | -293.888 M | -78.150 M | -221.638 M | -308.572 M | |
| Net income | -571.449 M | -557.556 M | -440.536 M | -348.431 M | -381.137 M | 215.413 M | -367.553 M | -251.150 M | |
| Depreciation | 15.461 M | 16.201 M | 18.016 M | 20.011 M | 22.335 M | 21.510 M | 23.819 M | 25.293 M | |
| Changes in inventories | 262.210 M | 290.911 M | 282.346 M | 296.995 M | 321.333 M | 316.929 M | 416.122 M | 447.345 M | |
| Changes in receivables | 189.668 M | 200.442 M | 195.945 M | 330.823 M | 336.148 M | 352.990 M | 394.151 M | 467.112 M | |
| Investing Cashflow | 658.710 M | 169.484 M | 38.536 M | 241.063 M | 67.800 M | -186.275 M | -62.584 M | -209.831 M | |
| Net Borrowings | -5.328 B | -4.608 B | -4.190 B | -3.588 B | -3.106 B | -2.841 B | -2.496 B | -1.956 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -50.290 M | -108.655 M | -121.358 M | -125.585 M | -121.470 M | -167.295 M | -166.911 M | -161.252 M | |
| Cash Change | 5.704 B | 5.069 B | 4.535 B | 3.833 B | 3.516 B | 3.174 B | 3.174 B | 2.793 B |